About
Giovanni Mariggi co-founded a biotech venture firm after pioneering asset‑centric investing—concentrating teams around single high‑conviction drug assets—and takes a hands‑on vaccine company‑building role, chairing ViceBio and serving on Curevo's board.
Invests in
BiotechDigital HealthHealthtechMedical Devices
Deals · 5
Illexcor TherapeuticsBoard seat
via Medicxi · filed May 2026 · $69M raise
FORE US BioBoard seat
via Medicxi · filed May 2025 · $46M raise
Curevo, Inc.Board seat
via Medicxi · filed Mar 2025 · $84.8M raise
CurevoLed round
via Medicxi
VicebioLed round
via Medicxi
Attribution from SEC filings, press coverage, and firm rosters.